These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4092295)
1. Studies on sustained-release dosage forms. III. Preparation of nifedipine suppositories and bioavailability in rabbits. Umeda T; Yokoyama T; Ohnishi N; Kuroda T; Kita Y; Kuroda K; Asada S Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3953-9. PubMed ID: 4092295 [No Abstract] [Full Text] [Related]
2. Studies on sustained-release dosage forms. IV. Pharmacokinetics after rectal administration of nifedipine suppositories in rabbits. Kuroda T; Yokoyama T; Umeda T; Ohnishi N; Kuroda K; Asada S Kobe J Med Sci; 1985 Jun; 31(3):117-31. PubMed ID: 4046504 [No Abstract] [Full Text] [Related]
3. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories. Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823 [No Abstract] [Full Text] [Related]
4. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits. Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103 [No Abstract] [Full Text] [Related]
5. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits. Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949 [No Abstract] [Full Text] [Related]
6. Application of nifedipine sustained-release suppositories to healthy volunteers. Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1294-8. PubMed ID: 3607954 [No Abstract] [Full Text] [Related]
8. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets]. Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations. Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332 [TBL] [Abstract][Full Text] [Related]
10. Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form. Hasegawa A; Nakagawa H; Sugimoto I Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1615-9. PubMed ID: 4042237 [No Abstract] [Full Text] [Related]
11. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine. Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321 [TBL] [Abstract][Full Text] [Related]
12. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions. Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728 [No Abstract] [Full Text] [Related]
13. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers. Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812 [TBL] [Abstract][Full Text] [Related]
14. Sustained-release pellets of nifedipine using microcrystals combined with MCC-based matrix. Ma J; Wang J; Cheng Z; Yin T; Teng H; Xu H; Tang X; Cai C Drug Dev Ind Pharm; 2015 Feb; 41(2):307-14. PubMed ID: 24320880 [TBL] [Abstract][Full Text] [Related]
15. Studies on improvement of pharmaceutical preparations prescribed in hospitals. V. Nifedipine hollow type suppository. Namiki N; Yokoyama H; Moriya K; Fukuda M; Takashima T; Tamura H; Yuasa H; Kanaya Y Drug Des Deliv; 1986 Nov; 1(2):167-73. PubMed ID: 3509330 [TBL] [Abstract][Full Text] [Related]
16. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state]. Meyer FP; Banditt P Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817 [TBL] [Abstract][Full Text] [Related]
17. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery. Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885 [TBL] [Abstract][Full Text] [Related]
18. [Preparation of sustained-release granules of nifedipine using a solid dispersion system and pharmacokinetic study after oral administration to rabbits]. Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K Yakugaku Zasshi; 1986 Dec; 106(12):1131-6. PubMed ID: 3559907 [No Abstract] [Full Text] [Related]
19. Development and Characterization Pulsatile Microspheres of Nifedipine for Hypertension. Taneja R; Gupta GD Recent Pat Drug Deliv Formul; 2017; 11(1):67-76. PubMed ID: 28201961 [TBL] [Abstract][Full Text] [Related]
20. Assessment of bioavailability of experimental controlled release microcapsules of nifedipine. Mallick S; Gupta BK; Ghosal SK Acta Pol Pharm; 2000; 57(3):175-80. PubMed ID: 11143705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]